跳至主要内容
临床试验/EUCTR2009-012300-69-NL
EUCTR2009-012300-69-NL进行中(未招募)不适用

Does vitamin D deficiency contribute to fatigue in patients in remission after treatment of gynaecological malignancy? - VItamine D Influence on FATigue In gynaecological MAlignancy (VIDIFATIMA- trial)

Meander Medisch Centrum0 个研究点开始时间: 2009年5月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Patients in remission after succesful treatment of ovary carcinoma, endometrial carcinoma, cervical carcinoma, tubal carcinoma or vulva carcinoma.
  • Remission is defined as a disease free status of at least 6 months after termination of the treatment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Patients with relapsing disease after initial succesful treatment of a gynaecological malignancy.
  • -Patients with relapsing disease during the study period or within 3 months after inclusion after initial succesful treatment of a gynaecological malignancy.
  • -Patients with renal failure; by definition a MDRD < 60 ml/min, because of the reduced effectiveness of 25(OH)vitamine D.

研究者

发起方
Meander Medisch Centrum

相似试验